Advertisement

Blepharitis Preferred Practice Pattern®

Published:October 23, 2018DOI:https://doi.org/10.1016/j.ophtha.2018.10.019
      AMERICAN ACADEMY™ OF OPHTHALMOLOGY
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic and Personal

      Subscribe:

      Subscribe to Ophthalmology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Scottish Intercollegiate Guidelines Network (SIGN)
        SIGN 50: a guideline developer's handbook.
        SIGN, Edinburgh2015 (SIGN publication no. 50). [November 2015].
        • Guyatt GH
        • Oxman AD
        • Vist GE
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • GRADE Working Group
        Organizations that have endorsed or that are using GRADE.
        http://www.gradeworkinggroup.org/
        Date accessed: September 19, 2018
        • McCulley JP
        • Dougherty JM
        • Deneau DG
        Classification of chronic blepharitis.
        Ophthalmology. 1982; 89: 1173-1180
        • Nichols KK
        • Foulks GN
        • Bron AJ
        • et al.
        The International Workshop on Meibomian Gland Dysfunction: executive summary.
        Invest Ophthalmol Vis Sci. 2011; 52: 1922-1929
        • American Academy of Ophthalmology Basic and Clinical Science Course Subcommittee
        Basic and Clinical Science Course. External Disease and Cornea: Section 8, 2017-2018.
        American Academy of Ophthalmology, San Francisco, CA2017: 71
        • Valenton MJ
        • Okumoto M
        Toxin-producing strains of Staphylococcus epidermidis (albus). Isolates from patients with staphylococcic blepharoconjunctivitis.
        Arch Ophthalmol. 1973; 89: 186-189
        • Seal D
        • Ficker L
        • Ramakrishnan M
        • Wright P
        Role of staphylococcal toxin production in blepharitis.
        Ophthalmology. 1990; 97: 1684-1688
        • Ficker L
        • Ramakrishnan M
        • Seal D
        • Wright P
        Role of cell-mediated immunity to staphylococci in blepharitis.
        Am J Ophthalmol. 1991; 111: 473-479
        • Bowman RW
        • Dougherty JM
        • McCulley JP
        Chronic blepharitis and dry eyes.
        Int Ophthalmol Clin. 1987; 27: 27-35
        • Aderem A
        • Ulevitch RJ
        Toll-like receptors in the induction of the innate immune response.
        Nature. 2000; 406: 782-787
        • Song PI
        • Abraham TA
        • Park Y
        • et al.
        The expression of functional LPS receptor proteins CD14 and toll-like receptor 4 in human corneal cells.
        Invest Ophthalmol Vis Sci. 2001; 42: 2867-2877
        • Lemp MA
        • Mahmood MA
        • Weiler HH
        Association of rosacea and keratoconjunctivitis sicca.
        Arch Ophthalmol. 1984; 102: 556-557
        • McCulley JP
        • Shine WE
        Meibomian secretions in chronic blepharitis.
        Adv Exp Med Biol. 1998; 438: 319-326
        • Schaumberg DA
        • Nichols JJ
        • Papas EB
        • Tong L
        • Uchino M
        • Nichols KK
        The International Workshop on Meibomian Gland Dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.
        Invest Ophthalmol Vis Sci. 2011; 52: 1994-2005
        • Yeotikar NS
        • Zhu H
        • Markoulli M
        • Nichols KK
        • Naduvilath T
        • Papas EB
        Functional and morphologic changes of meibomian glands in an asymptomatic adult population.
        Invest Ophthalmol Vis Sci. 2016; 57: 3996-4007
        • Stanek S
        Meibomian gland status comparison between active duty personnel and U.S. veterans.
        Mil Med. 2000; 165: 591-593
        • Lemp MA
        • Nichols KK
        Blepharitis in the United States 2009: a survey-based perspective on prevalence and treatment.
        Ocul Surf. 2009; 7: S1-S14
        • Schein OD
        • Munoz B
        • Tielsch JM
        • Bandeen-Roche K
        • West S
        Prevalence of dry eye among the elderly.
        Am J Ophthalmol. 1997; 124: 723-728
        • Lin PY
        • Tsai SY
        • Cheng CY
        • Liu JH
        • Chou P
        • Hsu WM
        Prevalence of dry eye among an elderly Chinese population in Taiwan: the Shihpai Eye Study.
        Ophthalmology. 2003; 110: 1096-1101
        • Uchino M
        • Dogru M
        • Yagi Y
        • et al.
        The features of dry eye disease in a Japanese elderly population.
        Optom Vis Sci. 2006; 83: 797-802
        • Jie Y
        • Xu L
        • Wu YY
        • Jonas JB
        Prevalence of dry eye among adult Chinese in the Beijing Eye Study.
        Eye (Lond). 2009; 23: 688-693
        • McCarty CA
        • Bansal AK
        • Livingston PM
        • Stanislavsky YL
        • Taylor HR
        The epidemiology of dry eye in Melbourne, Australia.
        Ophthalmology. 1998; 105: 1114-1119
        • Baum J
        Clinical manifestations of dry eye states.
        Trans Ophthalmol Soc U K. 1985; 104: 415-423
        • Stern ME
        • Beuerman RW
        • Fox RI
        • Gao J
        • Mircheff AK
        • Pflugfelder SC
        The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
        Cornea. 1998; 17: 584-589
        • Mathers WD
        Ocular evaporation in meibomian gland dysfunction and dry eye.
        Ophthalmology. 1993; 100: 347-351
        • Shine WE
        • McCulley JP
        Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality.
        Arch Ophthalmol. 1998; 116: 849-852
        • Kemal M
        • Sumer Z
        • Toker MI
        • Erdogan H
        • Topalkara A
        • Akbulut M
        The prevalence of Demodex folliculorum in blepharitis patients and the normal population.
        Ophthalmic Epidemiol. 2005; 12: 287-290
        • Gao YY
        • Di Pascuale MA
        • Li W
        • et al.
        High prevalence of Demodex in eyelashes with cylindrical dandruff.
        Invest Ophthalmol Vis Sci. 2005; 46: 3089-3094
        • Koo H
        • Kim TH
        • Kim KW
        • Wee SW
        • Chun YS
        • Kim JC
        Ocular surface discomfort and Demodex: effect of tea tree oil eyelid scrub in Demodex blepharitis.
        J Korean Med Sci. 2012; 27: 1574-1579
        • Browning DJ
        • Proia AD
        Ocular rosacea.
        Surv Ophthalmol. 1986; 31: 145-158
        • Jenkins MS
        • Brown SI
        • Lempert SL
        • Weinberg RJ
        Ocular rosacea.
        Am J Ophthalmol. 1979; 88: 618-622
        • Akpek EK
        • Merchant A
        • Pinar V
        • Foster CS
        Ocular rosacea: patient characteristics and follow-up.
        Ophthalmology. 1997; 104: 1863-1867
        • Deeks ED
        Ivermectin: a review in rosacea.
        Am J Clin Dermatol. 2015; 16: 447-452
        • American Academy of Ophthalmology Basic and Clinical Science Course Subcommittee
        Basic and Clinical Science Course. External Disease and Cornea: Section 8, 2017-2018.
        American Academy of Ophthalmology, San Francisco, CA2017: 69-70
        • Berg M
        • Liden S
        An epidemiological study of rosacea.
        Acta Derm Venereol. 1989; 69: 419-423
        • Chalmers DA
        Rosacea: recognition and management for the primary care provider.
        Nurse Pract. 1997; 22 (23-18, 30.): 18
        • Viswalingam M
        • Rauz S
        • Morlet N
        • Dart JK
        Blepharokeratoconjunctivitis in children: diagnosis and treatment.
        Br J Ophthalmol. 2005; 89: 400-403
        • Cetinkaya A
        • Akova YA
        Pediatric ocular acne rosacea: long-term treatment with systemic antibiotics.
        Am J Ophthalmol. 2006; 142: 816-821
        • Donaldson KE
        • Karp CL
        • Dunbar MT
        Evaluation and treatment of children with ocular rosacea.
        Cornea. 2007; 26: 42-46
        • Bamford JT
        • Gessert CE
        • Renier CM
        • et al.
        Childhood stye and adult rosacea.
        J Am Acad Dermatol. 2006; 55: 951-955
        • Lindsley K
        • Matsumura S
        • Hatef E
        • Akpek EK
        Interventions for chronic blepharitis.
        Cochrane Database Syst Rev. 2012; CD005556
        • O'Gallagher M
        • Banteka M
        • Bunce C
        • Larkin F
        • Tuft S
        • Dahlmann-Noor A
        Systemic treatment for blepharokeratoconjunctivitis in children.
        Cochrane Database Syst Rev. 2016; CD011750
        • O'Gallagher M
        • Bunce C
        • Hingorani M
        • Larkin F
        • Tuft S
        • Dahlmann-Noor A
        Topical treatments for blepharokeratoconjunctivitis in children.
        Cochrane Database Syst Rev. 2017; 2CD011965
        • Bozkurt B
        • Irkec MT
        • Atakan N
        • Orhan M
        • Geyik PO
        Lacrimal function and ocular complications in patients treated with systemic isotretinoin.
        Eur J Ophthalmol. 2002; 12: 173-176
        • Mathers WD
        • Shields WJ
        • Sachdev MS
        • Petroll WM
        • Jester JV
        Meibomian gland morphology and tear osmolarity: changes with Accutane therapy.
        Cornea. 1991; 10: 286-290
        • Fraunfelder FT
        • Fraunfelder FW
        • Edwards R
        Ocular side effects possibly associated with isotretinoin usage.
        Am J Ophthalmol. 2001; 132: 299-305
        • Egger SF
        • Huber-Spitzy V
        • Bohler K
        • et al.
        Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora.
        Acta Ophthalmol Scand. 1995; 73: 355-357
        • Martin NF
        • Rubinfeld RS
        • Malley JD
        • Manzitti V
        Giant papillary conjunctivitis and meibomian gland dysfunction blepharitis.
        CLAO J. 1992; 18: 165-169
        • Hammersmith KM
        • Cohen EJ
        • Blake TD
        • Laibson PR
        • Rapuano CJ
        Blepharokeratoconjunctivitis in children.
        Arch Ophthalmol. 2005; 123: 1667-1670
        • Hykin PG
        • Bron AJ
        Age-related morphological changes in lid margin and meibomian gland anatomy.
        Cornea. 1992; 11: 334-342
        • Daniel MC
        • O'Gallagher M
        • Hingorani M
        • Dahlmann-Noor A
        • Tuft S
        Challenges in the management of pediatric blepharokeratoconjunctivis/ocular rosacea.
        Expert Rev Ophthalmol. 2016; 11: 299-309
        • Wallace DK
        • Morse CL
        • Melia M
        • et al.
        Pediatric eye evaluations Preferred Practice Pattern®: I. Vision screening in the primary care and community setting; II. Comprehensive ophthalmic examination.
        Ophthalmology. 2018; 125 (or): P184-P227
        • Feder RS
        • Olsen TW
        • Prum Jr., BE
        • et al.
        Comprehensive adult medical eye evaluation Preferred Practice Pattern® guidelines.
        Ophthalmology. 2016; 123 (or): P209-236
        • Bron AJ
        • Benjamin L
        • Snibson GR
        Meibomian gland disease. Classification and grading of lid changes.
        Eye. 1991; 5: 395-411
        • Kheirkhah A
        • Blanco G
        • Casas V
        • Tseng SC
        Fluorescein dye improves microscopic evaluation and counting of demodex in blepharitis with cylindrical dandruff.
        Cornea. 2007; 26: 697-700
        • Gilberg S
        • Tse D
        Malignant eyelid tumors.
        Ophthalmol Clin North Am. 1992; 5: 261-285
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern®. Conjunctivitis.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Finis D
        • Pischel N
        • Schrader S
        • Geerling G
        Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction.
        Cornea. 2013; 32: 1549-1553
        • Blackie CA
        • Solomon JD
        • Scaffidi RC
        • Greiner JV
        • Lemp MA
        • Korb DR
        The relationship between dry eye symptoms and lipid layer thickness.
        Cornea. 2009; 28: 789-794
        • Jones SM
        • Weinstein JM
        • Cumberland P
        • Klein N
        • Nischal KK
        Visual outcome and corneal changes in children with chronic blepharokeratoconjunctivitis.
        Ophthalmology. 2007; 114: 2271-2280
        • Pflugfelder SC
        • Tseng SC
        • Sanabria O
        • et al.
        Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation.
        Cornea. 1998; 17: 38-56
        • Acharya N
        • Pineda 2nd, R
        • Uy HS
        • Foster CS
        Discoid lupus erythematosus masquerading as chronic blepharoconjunctivitis.
        Ophthalmology. 2005; 112: e19-23
        • Diaz-Valle D
        • Benitez del Castillo JM
        • Fernandez Acenero MJ
        • Pascual Allen D
        • Moriche Carretero M
        Bilateral lid margin ulcers as the initial manifestation of Crohn disease.
        Am J Ophthalmol. 2004; 138: 292-294
        • Lalwani GA
        • Flynn Jr., HW
        • Scott IU
        • et al.
        Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes.
        Ophthalmology. 2008; 115: 473-476
        • Olson RJ
        • Braga-Mele R
        • Chen SH
        • et al.
        Cataract in the adult eye Preferred Practice Pattern®.
        Ophthalmology. 2017; 124 (or): P1-P119
        • Key JE
        A comparative study of eyelid cleaning regimens in chronic blepharitis.
        CLAO J. 1996; 22: 209-212
        • Stroman DW
        • Mintun K
        • Epstein AB
        • et al.
        Reduction in bacterial load using hypochlorous acid hygiene solution on ocular skin.
        Clin Ophthalmol. 2017; 11: 707-714
        • Olson MC
        • Korb DR
        • Greiner JV
        Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction.
        Eye Contact Lens. 2003; 29: 96-99
        • Thode AR
        • Latkany RA
        Current and emerging therapeutic strategies for the treatment of meibomian gland dysfunction (MGD).
        Drugs. 2015; 75: 1177-1185
        • Torkildsen GL
        • Cockrum P
        • Meier E
        • Hammonds WM
        • Silverstein B
        • Silverstein S
        Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
        Curr Med Res Opin. 2011; 27: 171-178
        • Haque RM
        • Torkildsen GL
        • Brubaker K
        • et al.
        Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis.
        Cornea. 2010; 29: 871-877
        • Foulks GN
        • Borchman D
        • Yappert M
        • Kim SH
        • McKay JW
        Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations.
        Cornea. 2010; 29: 781-788
        • Cac NN
        • Messingham MJ
        • Sniezek PJ
        • Walling HW
        Stevens-Johnson syndrome induced by doxycycline.
        Cutis. 2007; 79: 119-122
        • Lau B
        • Mutyala D
        • Dhaliwal D
        A case report of doxycycline-induced Stevens-Johnson syndrome.
        Cornea. 2011; 30: 595-597
        • Ianaro A
        • Ialenti A
        • Maffia P
        • et al.
        Anti-inflammatory activity of macrolide antibiotics.
        J Pharmacol Exp Ther. 2000; 292: 156-163
        • Frucht-Pery J
        • Sagi E
        • Hemo I
        • Ever-Hadani P
        Efficacy of doxycycline and tetracycline in ocular rosacea.
        Am J Ophthalmol. 1993; 116: 88-92
        • Zengin N
        • Tol H
        • Gunduz K
        • Okudan S
        • Balevi S
        • Endogru H
        Meibomian gland dysfunction and tear film abnormalities in rosacea.
        Cornea. 1995; 14: 144-146
        • Dougherty JM
        • McCulley JP
        • Silvany RE
        • Meyer DR
        The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci.
        Invest Ophthalmol Vis Sci. 1991; 32: 2970-2975
        • Shine WE
        • McCulley JP
        • Pandya AG
        Minocycline effect on meibomian gland lipids in meibomianitis patients.
        Exp Eye Res. 2003; 76: 417-420
        • Quinn AG
        • Singer SB
        • Buncic JR
        Pediatric tetracycline-induced pseudotumor cerebri.
        J AAPOS. 1999; 3: 53-57
        • Chiu AM
        • Chuenkongkaew WL
        • Cornblath WT
        • et al.
        Minocycline treatment and pseudotumor cerebri syndrome.
        Am J Ophthalmol. 1998; 126: 116-121
        • American Academy of Ophthalmology Basic and Clinical Science Course Subcommittee
        Basic and Clinical Science Course. Update on General Medicine: Section 1, 2017-2018.
        American Academy of Ophthalmology, San Francisco, CA2017: 279
        • Meisler DM
        • Raizman MB
        • Traboulsi EI
        Oral erythromycin treatment for childhood blepharokeratitis.
        J AAPOS. 2000; 4: 379-380
        • Fraunfelder FT
        • Randall JA
        Minocycline-induced scleral pigmentation.
        Ophthalmology. 1997; 104: 936-938
        • Bradfield YS
        • Robertson DM
        • Salomao DR
        • Link TP
        • Rostvold JA
        Minocycline-induced ocular pigmentation.
        Arch Ophthalmol. 2003; 121: 144-145
        • Sanchez AR
        • Rogers 3rd, RS
        • Sheridan PJ
        Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity.
        Int J Dermatol. 2004; 43: 709-715
        • Modi S
        • Harting M
        • Rosen T
        Azithromycin as an alternative rosacea therapy when tetracyclines prove problematic.
        J Drugs Dermatol. 2008; 7: 898-899
        • Akhyani M
        • Ehsani AH
        • Ghiasi M
        • Jafari AK
        Comparison of efficacy of azithromycin vs. doxycycline in the treatment of rosacea: a randomized open clinical trial.
        Int J Dermatol. 2008; 47: 284-288
        • Igami TZ
        • Holzchuh R
        • Osaki TH
        • Santo RM
        • Kara-Jose N
        • Hida RY
        Oral azithromycin for treatment of posterior blepharitis.
        Cornea. 2011; 30: 1145-1149
        • Ray WA
        • Murray KT
        • Hall K
        • Arbogast PG
        • Stein CM
        Azithromycin and the risk of cardiovascular death.
        N Engl J Med. 2012; 366: 1881-1890
        • U.S. Food and Drug Administration
        FDA Drug Safety Communication. Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms.
        www.fda.gov/drugs/drugsafety/ucm341822.htm
        Date accessed: September 26, 2018
        • Filho PA
        • Hazarbassanov RM
        • Grisolia AB
        • Pazos HB
        • Kaiserman I
        • Gomes JA
        The efficacy of oral ivermectin for the treatment of chronic blepharitis in patients tested positive for Demodex spp.
        Br J Ophthalmol. 2011; 95: 893-895
        • van Zuuren EJ
        • Fedorowicz Z
        • Carter B
        • van der Linden MM
        • Charland L
        Interventions for rosacea.
        Cochrane Database Syst Rev. 2015; CD003262
        • Perry HD
        • Doshi-Carnevale S
        • Donnenfeld ED
        • Solomon R
        • Biser SA
        • Bloom AH
        Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction.
        Cornea. 2006; 25: 171-175
        • Macsai MS
        The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis).
        Trans Am Ophthalmol Soc. 2008; 106: 336-356
        • The Dry Eye Assessment and Management Study Research Group
        n–3 Fatty acid supplementation for the treatment of dry eye disease [published online ahead of print April 13 2018].
        N Engl J Med. 2018;
        • American Academy of Ophthalmology Cornea/External Disease Panel
        Preferred Practice Pattern®. Dry Eye Syndrome.
        American Academy of Ophthalmology, San Francisco, CA2018
        • Kheirkhah A
        • Casas V
        • Li W
        • Raju VK
        • Tseng SC
        Corneal manifestations of ocular Demodex infestation.
        Am J Ophthalmol. 2007; 143: 743-749
        • Gao YY
        • Di Pascuale MA
        • Li W
        • et al.
        In vitro and in vivo killing of ocular Demodex by tea tree oil.
        Br J Ophthalmol. 2005; 89: 1468-1473
        • Holzchuh FG
        • Hida RY
        • Moscovici BK
        • et al.
        Clinical treatment of ocular Demodex folliculorum by systemic ivermectin.
        Am J Ophthalmol. 2011; 151: 1030-1034
        • Margo CE
        • Mulla ZD
        Malignant tumors of the eyelid: a population-based study of non-basal cell and non-squamous cell malignant neoplasms.
        Arch Ophthalmol. 1998; 116: 195-198
        • Maskin SL
        Intraductal meibomian gland probing relieves symptoms of obstructive meibomian gland dysfunction.
        Cornea. 2010; 29: 1145-1152
        • Blackie CA
        • Coleman CA
        • Holland EJ
        The sustained effect (12 months) of a single-dose vectored thermal pulsation procedure for meibomian gland dysfunction and evaporative dry eye.
        Clin Ophthalmol. 2016; 10: 1385-1396
        • Greiner JV
        Long-term (12-month) improvement in meibomian gland function and reduced dry eye symptoms with a single thermal pulsation treatment.
        Clin Exp Ophthalmol. 2013; 41: 524-530
        • Murphy O
        • O'Dwyer V
        • Lloyd-McKernan A
        The efficacy of tea tree face wash, 1, 2-Octanediol and microblepharoexfoliation in treating Demodex folliculorum blepharitis.
        Cont Lens Anterior Eye. 2018; 41: 77-82
        • Toyos R
        • McGill W
        • Briscoe D
        Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction; a 3-year retrospective study.
        Photomed Laser Surg. 2015; 33: 41-46
        • Yin Y
        • Liu N
        • Gong L
        • Song N
        Changes in the meibomian gland after exposure to intense pulsed light in meibomian gland dysfunction (MGD) patients.
        Curr Eye Res. 2018; 43: 308-313
        • Coleman AL
        • Yu F
        Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999.
        Ophthalmology. 2008; 115: 18-25
        • American Academy of Ophthalmology Basic and Clinical Science Course Subcommittee
        Basic and Clinical Science Course. External Disease and Cornea: Section 8, 2017-2018.
        American Academy of Ophthalmology, San Francisco, CA2017: 55 (72-6.)
        • Lemp MA
        Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.
        CLAO J. 1995; 21: 221-232
        • Foulks GN
        • Bron AJ
        Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading.
        Ocul Surf. 2003; 1: 107-126
        • Bron AJ
        • Tiffany JM
        The contribution of meibomian disease to dry eye.
        Ocul Surf. 2004; 2: 149-165
        • Mertzanis P
        • Abetz L
        • Rajagopalan K
        • et al.
        The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.
        Invest Ophthalmol Vis Sci. 2005; 46: 46-50
        • Miljanovic B
        • Dana R
        • Sullivan DA
        • Schaumberg DA
        Impact of dry eye syndrome on vision-related quality of life.
        Am J Ophthalmol. 2007; 143: 409-415